JAK1 and type 2 diabetes mellitus: In this study, we investigated the effect of the JAK1 inhibitor tofacitinib citrate in DR-related BRB leakage in a mouse model of T2DM, the BKS.Cg-Dock7m+/+LeprdbJ mice (referred as db/db in this paper).